25054547|t|Characterization of a novel BCHE "silent" allele: point mutation (p.Val204Asp) causes loss of activity and prolonged apnea with suxamethonium.
25054547|a|Butyrylcholinesterase deficiency is characterized by prolonged apnea after the use of muscle relaxants (suxamethonium or mivacurium) in patients who have mutations in the BCHE gene. Here, we report a case of prolonged neuromuscular block after administration of suxamethonium leading to the discovery of a novel BCHE variant (c.695T>A, p.Val204Asp). Inhibition studies, kinetic analysis and molecular dynamics were undertaken to understand how this mutation disrupts the catalytic triad and determines a "silent" phenotype. Low activity of patient plasma butyrylcholinesterase with butyrylthiocholine (BTC) and benzoylcholine, and values of dibucaine and fluoride numbers fit with heterozygous atypical silent genotype. Electrophoretic analysis of plasma BChE of the proband and his mother showed that patient has a reduced amount of tetrameric enzyme in plasma and that minor fast-moving BChE components: monomer, dimer, and monomer-albumin conjugate are missing. Kinetic analysis showed that the p.Val204Asp/p.Asp70Gly-p.Ala539Thr BChE displays a pure Michaelian behavior with BTC as the substrate. Both catalytic parameters Km = 265 uM for BTC, two times higher than that of the atypical enzyme, and a low Vmax are consistent with the absence of activity against suxamethonium. Molecular dynamic (MD) simulations showed that the overall effect of the mutation p.Val204Asp is disruption of hydrogen bonding between Gln223 and Glu441, leading Ser198 and His438 to move away from each other with subsequent disruption of the catalytic triad functionality regardless of the type of substrate. MD also showed that the enzyme volume is increased, suggesting a pre-denaturation state. This fits with the reduced concentration of p.Ala204Asp/p.Asp70Gly-p.Ala539Thr tetrameric enzyme in the plasma and non-detectable fast moving-bands on electrophoresis gels.
25054547	28	32	BCHE	GeneOrGeneProduct	590
25054547	66	77	p.Val204Asp	SequenceVariant	p|SUB|V|204|D
25054547	117	122	apnea	DiseaseOrPhenotypicFeature	D001049
25054547	128	141	suxamethonium	ChemicalEntity	D013390
25054547	143	175	Butyrylcholinesterase deficiency	DiseaseOrPhenotypicFeature	C537417
25054547	206	211	apnea	DiseaseOrPhenotypicFeature	D001049
25054547	229	245	muscle relaxants	ChemicalEntity	-
25054547	247	260	suxamethonium	ChemicalEntity	D013390
25054547	264	274	mivacurium	ChemicalEntity	D000077590
25054547	279	287	patients	OrganismTaxon	9606
25054547	314	318	BCHE	GeneOrGeneProduct	590
25054547	361	380	neuromuscular block	DiseaseOrPhenotypicFeature	D055191
25054547	405	418	suxamethonium	ChemicalEntity	D013390
25054547	455	459	BCHE	GeneOrGeneProduct	590
25054547	469	477	c.695T>A	SequenceVariant	c|SUB|T|695|A
25054547	479	490	p.Val204Asp	SequenceVariant	p|SUB|V|204|D
25054547	683	690	patient	OrganismTaxon	9606
25054547	698	719	butyrylcholinesterase	GeneOrGeneProduct	590
25054547	725	743	butyrylthiocholine	ChemicalEntity	D002092
25054547	745	748	BTC	ChemicalEntity	D002092
25054547	754	768	benzoylcholine	ChemicalEntity	D001588
25054547	784	793	dibucaine	ChemicalEntity	D003992
25054547	798	806	fluoride	ChemicalEntity	D005459
25054547	898	902	BChE	GeneOrGeneProduct	590
25054547	945	952	patient	OrganismTaxon	9606
25054547	1032	1036	BChE	GeneOrGeneProduct	590
25054547	1141	1152	p.Val204Asp	SequenceVariant	p|SUB|V|204|D
25054547	1153	1163	p.Asp70Gly	SequenceVariant	rs1799807
25054547	1164	1175	p.Ala539Thr	SequenceVariant	rs1803274
25054547	1176	1180	BChE	GeneOrGeneProduct	590
25054547	1222	1225	BTC	ChemicalEntity	D002092
25054547	1286	1289	BTC	ChemicalEntity	D002092
25054547	1409	1422	suxamethonium	ChemicalEntity	D013390
25054547	1506	1517	p.Val204Asp	SequenceVariant	p|SUB|V|204|D
25054547	1868	1879	p.Ala204Asp	SequenceVariant	p|SUB|A|204|D
25054547	1880	1890	p.Asp70Gly	SequenceVariant	rs1799807
25054547	1891	1902	p.Ala539Thr	SequenceVariant	rs1803274
25054547	Positive_Correlation	C537417	D000077590	No
25054547	Positive_Correlation	C537417	D013390	No
25054547	Positive_Correlation	C537417	p|SUB|V|204|D	Novel
25054547	Association	rs1803274	D002092	Novel
25054547	Association	rs1799807	rs1803274	Novel
25054547	Association	rs1799807	D002092	Novel
25054547	Positive_Correlation	D055191	c|SUB|T|695|A	Novel
25054547	Positive_Correlation	D055191	D013390	Novel
25054547	Positive_Correlation	D055191	p|SUB|V|204|D	Novel
25054547	Negative_Correlation	590	C537417	No
25054547	Association	590	D002092	Novel
25054547	Association	590	D055191	Novel
25054547	Association	590	D013390	No
25054547	Association	590	D001049	No
25054547	Association	D013390	c|SUB|T|695|A	Novel
25054547	Positive_Correlation	D013390	D001049	No
25054547	Positive_Correlation	D001049	D000077590	No
25054547	Association	p|SUB|V|204|D	rs1803274	Novel
25054547	Association	p|SUB|V|204|D	rs1799807	Novel
25054547	Association	p|SUB|V|204|D	D002092	Novel
25054547	Association	p|SUB|V|204|D	D013390	Novel
25054547	Positive_Correlation	p|SUB|V|204|D	D001049	Novel